Access hundreds of peer-reviewed cognitive research papers published by leading neuroscientists using Cogstate technology.



Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries.

Authors: Buckley RF, Burnham S, Dekhtyar M, Martin C, Papp KV, Rentz DM, Sparks KP, Sperling RA

Journal: The Journal of Prevention of Alzheimer's Disease

Volume & Issue: 4 & 1

Page No.: 3-11

DOI: 10.14283/jpad.2017.1.

Year Published: 2018

BACKGROUND As prevention trials for Alzheimer’s disease move into asymptomatic populations, identifying older individuals who manifest the earliest cognitive signs of Alzheimer’s disease is critical. Computerized cognitive testing has the potential to replace current gold standard paper and pencil measures and may be a more efficient means of assessing cognition. However, more empirical evidence about […]

Computerized vs. Paper-Pencil Assessment of Cognitive Change following Acute Ischemic Stroke.

Authors: Gagnon MM, Laforce R Jr

Journal: Journal of Neurological Disorders

Volume & Issue: 4 & 8

Page No.: 317

DOI: 10.4172/2329-6895.1000317

Year Published: 2017

IMPORTANCE: Cognitive impairment is common among patients with stroke and early recognition can optimize patient care. OBJECTIVE: To determine the validity of computerized cognitive testing in an adult population with acute ischemic stroke. DESIGN: Validation study comparing computerized vs paper-pencil assessments at two time points three months apart in a stroke unit. MAIN OUTCOME: Correlation […]

Reliability and validity of the CogState computerized battery in patients with seizure disorders and healthy young adults: comparison with standard neuropsychological tests.

Authors: Bowden SC, Cook MJ, Fratti S

Journal: The Clinical Neuropsychologist

Page No.: 1-18

Year Published: 2016

OBJECTIVE: The aim was to examine the reliability and validity of two measures of learning and memory within the CogState Computerized Battery: the One Card Learning (OCL) and the Continuous Paired Associative Learning (CPAL). Comparison of various reliable change measures was also included to examine rate of correct cognitive change classification, in particular, when using […]

Prospective, Head-to-Head Study of Three Computerized Neurocognitive Assessment Tools (CNTs): Reliability and Validity for the Assessment of Sport-Related Concussion.

Authors: Barr WB, Guskiewicz K, Hammeke TA, LaRoche AA, Lerner EB, McCrea MA, Nelson LD, Pfaller AY, Randolph C

Journal: Journal of the International Neuropsychological Society

Volume & Issue: 22 & 1

Page No.: 24-37

DOI: 10.1017/S1355617715001101

Year Published: 2016

Limited data exist comparing the performance of computerized neurocognitive tests (CNTs) for assessing sport-related concussion. We evaluated the reliability and validity of three CNTs-ANAM, Axon Sports/Cogstate Sport, and ImPACT-in a common sample. High school and collegiate athletes completed two CNTs each at baseline. Concussed (n=165) and matched non-injured control (n=166) subjects repeated testing within 24 […]

Comparison of Cognitive Performance on the Cogstate Brief Battery When Taken In-Clinic, In-Group, and Unsupervised.

Authors: Brunwin JW, Crawford CD, Cromer JA, Harel BT, Maruff P, Mayes LC, Valadka JS, Yu K

Journal: The Clinical Neuropsychologist

Volume & Issue: 29 & 4

Page No.: 542-58

DOI: 10.1080/13854046.2015.1054437

Year Published: 2015

OBJECTIVE: Repeat cognitive assessment comparing post-injury performance to a pre-injury baseline is common in concussion management. Although post-injury tests are typically administered in clinical settings, baseline tests may be conducted individually with one-on-one supervision, in a group with supervision, or without supervision. The extent to which these different test settings affect cognitive performance is not […]

The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer’s disease.

Authors: Cutler NR, Hironaka DY, Reich LA, Seifert RD, Shrotriya RC, Sramek JJ, Veroff AE

Journal: Annals of the New York Academy of Sciences

Volume & Issue: 695

Page No.: 332-6

DOI: 10.1111/j.1749-6632.1993.tb23079.x

Year Published: 1993

BMY 21,502 is a nootropic which protects memory and enhances long-term potentiation according to preclinical findings. Alzheimer’s disease (AD) patients who were diagnosed by DSM-III-R and NINCDS-ADRDA criteria were enrolled in a 12-week double-blind investigation of BMY 21,502 vs. placebo at 300 mg tid. The study design included a 1-week placebo lead-in and a 4-week […]

Efficacy and safety of BMY 21,502 in Alzheimer disease.

Authors: Cutler NR, Hironaka DY, Shrotriya RC, Sramek JJ, Veroff AE

Journal: The Annals of Pharmacotherapy

Volume & Issue: 30 & 12

Page No.: 1376-80

Year Published: 1996

OBJECTIVE: To assess the efficacy and safety of BMY 21,502, a nootropic agent, in patients with mild-to-moderate Alzheimer disease. DESIGN AND PARTICIPANTS: Sixty-nine patients with Alzheimer disease (28 men, 41 women, mean age 72 y, range 54-92, mean Mini-Mental State Examination (MMSE) score 23.5) were randomized to receive either BMY 21,502 (n = 34) or […]

Motor imagery training ameliorates motor clumsiness in children.

Authors: Maruff P, Thomas PR, Wilson PH

Journal: Journal of Child Neurology

Volume & Issue: 17 & 7

Page No.: 491-8

DOI: 10.1177/088307380201700704

Year Published: 2002

Children with impaired motor coordination (or developmental coordination disorder) have difficulty representing internally the visuospatial coordinates of intended movements. We have proposed that this deficit reflects impairment in the generation of forward models of the efference copy of intended movements-the efference-copy-deficit hypothesis. In this study, we challenged this hypothesis by examining the efficacy of an […]

Mild cognitive impairment can be detected by multiple assessments in a single day.

Authors: Collie A, Darby D, Maruff P, McStephen M

Journal: Neurology

Volume & Issue: 59 & 7

Page No.: 1042-6

Year Published: 2002

BACKGROUND: Reliable detection of mild cognitive impairment (MCI), in many cases preceding AD, is important in determining the efficacy of emerging treatments. The operational definition of MCI is currently imprecise and would be improved by objective criteria. Inherent in the transition from MCI to AD is cognitive decline, which can be detected using multiple assessments […]

Status of computerized cognitive testing in aging: a systematic review.

Authors: Howieson D, Kaye J, Seelye A, Webbe F, Wild K

Journal: Alzheimer's & Dementia

Volume & Issue: 6 & 4

Page No.: 428-37

DOI: 10.1016/j.jalz.2008.07.003

Year Published: 2008

BACKGROUND: Early detection of cognitive decline in the elderly has become of heightened importance in parallel with the recent advances in therapeutics. Computerized assessment might be uniquely suited to early detection of changes in cognition in the elderly. We present here a systematic review of the status of computer-based cognitive testing, focusing on detection of […]

Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies.

Authors: Darby D, Fredrickson A, Fredrickson J, Maruff P, Moore L, Sach J, Woodward M

Journal: Neuroepidemiology

Volume & Issue: 34 & 2

Page No.: 65-75

DOI: 10.1159/000264823

Year Published: 2010

BACKGROUND: Computerized cognitive testing has the potential to be an effective way to assess and monitor cognition in large neuroepidemiological studies. CogState is a game-like computerized test with demonstrated validity and reliability that has shown sensitivity to decline in older individuals over time. This study aimed to evaluate the serial usability of the test specifically […]